What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?

What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?

Бібліографічні деталі
Автори: Cansu Akleylek, Seray Gizem Gür, Ibrahim Halil Sever, Safiye Koçulu Demir, Esin Cevik, Egemen Eken, Zafer Gökkaya, Yonca Çağatay, Neslihan Yılmaz
Формат: Стаття
Мова:English
Опубліковано: AVES 2022-07-01
Серія:European Journal of Rheumatology
Онлайн доступ:https://www.eurjrheumatol.org/en/what-are-the-main-factors-affecting-the-outcome-of-tocilizumab-therapy-in-covid-19-induced-cytokine-release-syndrome-133435

Інтернет

https://www.eurjrheumatol.org/en/what-are-the-main-factors-affecting-the-outcome-of-tocilizumab-therapy-in-covid-19-induced-cytokine-release-syndrome-133435

Схожі ресурси